Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: A 24-week follow-up study

[1]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[2]  M. Berk,et al.  A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[3]  R. Adamiec,et al.  [Paraoxonase--important enzyme of the lipid metabolism and potential ally in the antiatherosclerotic treatment]. , 2010, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.

[4]  X. Chu,et al.  Common polymorphisms in ITGA2, PON1 and THBS2 are associated with coronary atherosclerosis in a candidate gene association study of the Chinese Han population , 2010, Journal of Human Genetics.

[5]  R. H. Mohamed,et al.  The relationship between paraoxonase1-192 polymorphism and activity with coronary artery disease. , 2010, Clinical biochemistry.

[6]  J. Szemraj,et al.  Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients , 2009, Human psychopharmacology.

[7]  G. Réus,et al.  Increased oxidative stress in submitochondrial particles into the brain of rats submitted to the chronic mild stress paradigm. , 2009, Journal of psychiatric research.

[8]  Di Zhang,et al.  Antidepressant effect of Shudihuang on mice exposed to unpredictable chronic mild stress. , 2009, Journal of ethnopharmacology.

[9]  G. Réus,et al.  Effects of chronic mild stress on the oxidative parameters in the rat brain , 2009, Neurochemistry International.

[10]  J. Szemraj,et al.  Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment , 2009, Pharmacological reports : PR.

[11]  N. Banu,et al.  In vivo antioxidant status: A putative target of antidepressant action , 2009, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[12]  J. Witztum,et al.  The role of oxidized phospholipids in mediating lipoprotein(a) atherogenicity , 2008, Current opinion in lipidology.

[13]  G. Hughes,et al.  Oxidation of LDL and its clinical implication. , 2008, Autoimmunity reviews.

[14]  E. Bastounis,et al.  Serum oxidizability, total antioxidant status and albumin serum levels in patients with aneurysmal or arterial occlusive disease. , 2008, Clinical biochemistry.

[15]  S. Selek,et al.  The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode. , 2008, Journal of affective disorders.

[16]  N. Banu,et al.  Antioxidant potential of fluoxetine in comparison to Curcuma longa in restraint-stressed rats. , 2007, European journal of pharmacology.

[17]  S. Frangou,et al.  Evidence for oxidative stress in the frontal cortex in patients with recurrent depressive disorder—a postmortem study , 2007, Psychiatry Research.

[18]  M. Nazıroğlu,et al.  Protective Effects of Lamotrigine, Aripiprazole and Escitalopram on Depression-induced Oxidative Stress in Rat Brain , 2007, Neurochemical Research.

[19]  A. Sarandol,et al.  Major depressive disorder is accompanied with oxidative stress: short‐term antidepressant treatment does not alter oxidative–antioxidative systems , 2007, Human psychopharmacology.

[20]  S. Selek,et al.  Adenosine deaminase, nitric oxide, superoxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. , 2007, Archives of medical research.

[21]  A. C. Uguz,et al.  Venlafaxine Modulates Depression-Induced Oxidative Stress in Brain and Medulla of Rat , 2007, Neurochemical Research.

[22]  A. Sarandol,et al.  Oxidation of apolipoprotein B-containing lipoproteins and serum paraoxonase/arylesterase activities in major depressive disorder , 2006, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[23]  E. Sarandöl,et al.  Lipid and protein oxidation and antioxidant status in patients with angiographically proven coronary artery disease. , 2006, Clinical biochemistry.

[24]  F. Kobayashi,et al.  Possible connections among job stress, depressive symptoms, lipid modulation and antioxidants. , 2006, Journal of affective disorders.

[25]  Merete Osler,et al.  Effect of smoking reduction on lung cancer risk. , 2005, JAMA.

[26]  Y. Probst,et al.  Low plasma vitamin E levels in major depression: diet or disease? , 2005, European Journal of Clinical Nutrition.

[27]  G. Mantovani,et al.  Cancer-related anorexia/cachexia syndrome and oxidative stress: an innovative approach beyond current treatment. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[28]  P. Holvoet.  Oxidized LDL and coronary heart disease , 2004, Acta cardiologica.

[29]  A. Sherwood,et al.  Depression as a Risk Factor for Coronary Artery Disease: Evidence, Mechanisms, and Treatment , 2004, Psychosomatic medicine.

[30]  S. Khanzode,et al.  Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors , 2003, Redox report : communications in free radical research.

[31]  P. McElduff,et al.  Low Paraoxonase Activity Predicts Coronary Events in the Caerphilly Prospective Study , 2003, Circulation.

[32]  M. Bekaroǧlu,et al.  Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. , 2001, Journal of affective disorders.

[33]  R. Pioli,et al.  Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness. , 2000, Journal of affective disorders.

[34]  P. Holvoet.  Endothelial dysfunction, oxidation of low-density lipoprotein, and cardiovascular disease. , 1999, Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis.

[35]  M. Huff,et al.  Oxidized type IV hypertriglyceridemic VLDL-remnants cause greater macrophage cholesteryl ester accumulation than oxidized LDL. , 1998, Journal of lipid research.

[36]  M. Rubenfire,et al.  Clinical predictors of oxidized low-density lipoprotein in patients with coronary artery disease. , 1997, The American journal of cardiology.

[37]  G. Luc,et al.  Rapid quantification of alpha-tocopherol in plasma and low- and high-density lipoproteins. , 1996, Clinical chemistry.

[38]  L. V. Van Gaal,et al.  A rapid and simple method for measuring the susceptibility of low-density-lipoprotein and very-low-density-lipoprotein to copper-catalyzed oxidation. , 1994, Clinica chimica acta; international journal of clinical chemistry.

[39]  H. Esterbauer,et al.  The role of lipid peroxidation and antioxidants in oxidative modification of LDL. , 1992, Free radical biology & medicine.

[40]  I. Young,et al.  Measurement of Malondialdehyde in Plasma by High Performance Liquid Chromatography with Fluorimetric Detection , 1991, Annals of clinical biochemistry.

[41]  B. La Du,et al.  The human serum paraoxonase/arylesterase polymorphism. , 1983, American journal of human genetics.

[42]  R. Levy,et al.  Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.

[43]  D. Leibfritz,et al.  Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.

[44]  L. Havekes,et al.  Oxidized VLDL induces less triglyceride accumulation in J774 macrophages than native VLDL due to an impaired extracellular lipolysis. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[45]  C. Burtis.  Tietz textbook of Clinical Chemistry , 1994 .

[46]  B. Leonard,et al.  Catalase, superoxide dismutase and glutathione peroxidase activity in neutrophils of sham-operated and olfactory-bulbectomised rats following chronic treatment with desipramine and lithium chloride. , 1994, Neuropsychobiology.

[47]  A. Brock,et al.  A New Automated Method for Phenotyping Arylesterase (EC 3.1.1.2) Based Upon Inhibition of Enzymatic Hydrolysis of 4-Nitrophenyl Acetate by Phenyl Acetate , 1992, European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies.

[48]  S. Aust,et al.  Microsomal lipid peroxidation. , 1978, Methods in enzymology.